Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
500,010
-
Share change
-
+96,691
-
Total reported value
-
$47,602,785
-
Price per share
-
$95.20
-
Number of holders
-
22
-
Value change
-
+$9,175,497
-
Number of buys
-
5
-
Number of sells
-
10
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q4 2025
As of 31 Dec 2025,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
500,010 shares.
The largest 10 holders included
SG Americas Securities, LLC, Aberdeen Group plc, Crocodile Capital Partners GmbH, BANQUE PICTET & CIE SA, Systrade AG, Mirabaud & Cie SA, Perigon Wealth Management, LLC, Compagnie Lombard Odier SCmA, Generali Investments CEE, investicni spolecnost, a.s., and Finward Bancorp.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.